Centiva Capital’s Medtronic MDT Stock Holding History

Centiva Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,020	Closed	-$629K	–	1408
2021 Q3	$629K	Buy	+5,020	New	+$650K	0.04%	541

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Centiva Capital's MDT Position: Q2 2026 in Review

Centiva Capital sold out of Medtronic (MDT) in Q2 2026, closing a stake of 22,333 shares — an estimated $1.94M sold.

Centiva Capital first reported a position in MDT in Q4 2019 and held it in 18 quarters. The position peaked at $6.94M in Q3 2024. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Centiva Capital reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
Centiva Capital sold 22,333 Medtronic shares in Q2 2026, an estimated $1.94M.
Centiva Capital first reported a position in Medtronic in Q4 2019 and held it in 18 quarters.
Centiva Capital's Medtronic position peaked at $6.94M in Q3 2024.
2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.